Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin barrier proteins are a group of structural and functional proteins primarily located in the stratum corneum (SC) that maintain the integrity, hydration, and protective functions of the skin. They prevent transepidermal water loss (TEWL) and protect against external insults such as pathogens, allergens, and chemicals. Key proteins include filaggrin (FLG), involucrin, loricrin, small proline-rich proteins (SPRPs), keratins, and desmosomal proteins like desmoglein 1 (DSG1) and desmocollin 1 (DSC1). Mutations or dysregulation of these proteins can lead to compromised barrier function and skin diseases like atopic dermatitis and ichthyosis vulgaris.
N/A - These are structural proteins, not typically drug targets directly. Drugs often target pathways regulating their expression or compensate for their deficiency.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin Barrier Proteins.